Quidelortho Corporation

03/24/2026 | Press release | Distributed by Public on 03/24/2026 14:41

Initial Statement of Beneficial Ownership (Form 3)

FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Hanson Bryan Michael
2. Date of Event Requiring Statement (Month/Day/Year)
02/04/2026
3. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [QDEL]
(Last) (First) (Middle)
9975 SUMMERS RIDGE ROAD
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
EVP Global Port. Mgmt & Mkting
5. If Amendment, Date Original Filed (Month/Day/Year)
(Street)
SAN DIEGO, CA 92121
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 900 D
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Incentive Stock Options (1) 08/22/2027 Common Stock 188 $92.23 D
Incentive Stock Options (1) 08/22/2027 Common Stock 282 $92.23 D
Incentive Stock Options (1) 12/20/2029 Common Stock 1,050 $119.06 D
Incentive Stock Options (1) 08/21/2030 Common Stock 420 $119.06 D
Incentive Stock Options (1) 03/18/2032 Common Stock 291 $179.06 D
Incentive Stock Options (1) 03/18/2032 Common Stock 291 $179.06 D
Non-Qualified Stock Options (1) 12/20/2029 Common Stock 1,050 $119.06 D
Non-Qualified Stock Options (1) 08/21/2030 Common Stock 420 $119.06 D
Non-Qualified Stock Options (2) 04/26/2033 Common Stock 4,377 $88.67 D
Non-Qualified Stock Options (3) 04/22/2034 Common Stock 10,522 $39.08 D
Non-Qualified Stock Options (4) 07/01/2035 Common Stock 17,392 $29.79 D
Non-Qualified Stock Options (5) 01/30/2036 Common Stock 36,150 $27.17 D
Restricted Stock Units (6) (6) Common Stock 1,459 (7) D
Restricted Stock Units (8) (8) Common Stock 446 (7) D
Restricted Stock Units (9) (9) Common Stock 7,016 (7) D
Restricted Stock Units (4) (4) Common Stock 17,392 (7) D
Restricted Stock Units (10) (10) Common Stock 36,152 (7) D

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Hanson Bryan Michael
9975 SUMMERS RIDGE ROAD
SAN DIEGO, CA 92121
EVP Global Port. Mgmt & Mkting

Signatures

/s/ Euna Greene, attorney-in-fact for Bryan M. Hanson 03/24/2026
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Vested in full.
(2) 2,918 shares are vested in full; the remaining 1,459 shares will vest on April 26, 2026.
(3) 3,507 shares are vested in full; 3,507 shares will vest on April 22, 2026 and 3,508 shares will vest on April 22, 2027.
(4) 5,797 shares will vest on July 1, 2026, 5,797 shares will vest on July 1, 2027 and 5,798 shares will vest on July 1, 2028.
(5) 36,150 shares will vest in equal installments on January 30, 2027, January 30 ,2028 and January 30, 2029.
(6) 1,459 shares will vest on April 26, 2026.
(7) Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
(8) 446 shares will vest on August 15, 2026.
(9) 7,016 shares will vest in equal installments on April 22, 2026 and April 22, 2027.
(10) 12,050 shares will vest on January 30, 2027; the remaining 24,102 shares will vest in equal installments on January 30, 2028 and January 30, 2029.

Remarks:
This Form 3 is being filed late due to unanticipated delays in receiving the Reporting Person's EDGAR codes
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.
Quidelortho Corporation published this content on March 24, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 24, 2026 at 20:41 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]